Khan D A, Yocum M W
Mayo Clinic and Foundation.
Ann Allergy. 1994 Oct;73(4):370-4.
Only a few groups have reported on idiopathic anaphylaxis. We analyzed our experience with idiopathic anaphylaxis, especially in regards to prognosis.
Thirty-seven patients with the diagnosis of idiopathic anaphylaxis were retrospectively identified by a medical records search from 1989-1992. Thirty-five patients were evaluable and a telephone questionnaire was conducted to determine the current treatment and course of their idiopathic anaphylaxis since their initial evaluation.
Patient ages ranged from 26 to 71 years (mean 48), 72% were women, and 43% were atopic. Frequent episodes of idiopathic anaphylaxis (> 5/year) occurred in 31%. At follow-up (mean 2.5 years), 21 patients (60%) had resolution of idiopathic anaphylaxis, and the frequency of anaphylaxis was decreased in nine, increased in two, and the same in three patients. Only three patients were still having frequent episodes and two required chronic glucocorticoids. Patients with frequent idiopathic anaphylaxis treated with only antihistamines and adrenergics underwent remission or improvement as frequently as those treated with chronic glucocorticoids.
These results are similar to other reports of idiopathic anaphylaxis and indicate a generally favorable prognosis. Some patients with frequent idiopathic anaphylaxis improved without the need for glucocorticoids. Well controlled studies may be required to analyze the role of glucocorticoids in this disease.
仅有少数研究小组报道过特发性过敏反应。我们分析了我们在特发性过敏反应方面的经验,尤其是关于预后情况。
通过检索1989年至1992年的病历,回顾性确定了37例诊断为特发性过敏反应的患者。35例患者可进行评估,并通过电话问卷调查来确定自初次评估以来他们特发性过敏反应的当前治疗情况和病程。
患者年龄在26岁至71岁之间(平均48岁),72%为女性,43%为特应性体质。31%的患者特发性过敏反应发作频繁(>5次/年)。在随访(平均2.5年)时,21例患者(60%)的特发性过敏反应得到缓解,9例患者过敏反应频率降低,2例增加,3例不变。只有3例患者仍频繁发作,2例需要长期使用糖皮质激素。仅用抗组胺药和肾上腺素能药物治疗频繁特发性过敏反应的患者与用长期糖皮质激素治疗的患者缓解或改善情况相同。
这些结果与其他关于特发性过敏反应的报道相似,表明总体预后良好。一些频繁发作特发性过敏反应的患者无需使用糖皮质激素即可改善。可能需要进行严格对照研究来分析糖皮质激素在这种疾病中的作用。